Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.

Cernoch PS, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group.

Dig Dis Sci. 2019 Dec 3. doi: 10.1007/s10620-019-05978-9. [Epub ahead of print]

PMID:
31797187
2.

Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn's Disease.

Schoepfer A, Santos J, Fournier N, Schibli S, Spalinger J, Vavricka S, Safroneeva E, Aslan N, Rogler G, Braegger C, Nydegger A.

J Crohns Colitis. 2019 Sep 27;13(10):1334-1342. doi: 10.1093/ecco-jcc/jjz065.

PMID:
31002741
3.

Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease.

Yilmaz B, Juillerat P, Øyås O, Ramon C, Bravo FD, Franc Y, Fournier N, Michetti P, Mueller C, Geuking M, Pittet VEH, Maillard MH, Rogler G; Swiss IBD Cohort Investigators, Wiest R, Stelling J, Macpherson AJ.

Nat Med. 2019 Apr;25(4):701. doi: 10.1038/s41591-019-0411-9.

PMID:
30846883
4.

[Vegan diet in children : what potential deficits to monitor ?]

Petit LM, Nydegger A, Müller P.

Rev Med Suisse. 2019 Feb 13;15(638):373-375. French.

PMID:
30762997
5.

Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

Pittet V, Michetti P, Mueller C, Braegger CP, von Känel R, Schoepfer A, Macpherson AJ, Rogler G; Swiss IBD Cohort Study Group.

Int J Epidemiol. 2019 Apr 1;48(2):385-386f. doi: 10.1093/ije/dyy298. No abstract available.

PMID:
30689927
6.

Microbial network disturbances in relapsing refractory Crohn's disease.

Yilmaz B, Juillerat P, Øyås O, Ramon C, Bravo FD, Franc Y, Fournier N, Michetti P, Mueller C, Geuking M, Pittet VEH, Maillard MH, Rogler G; Swiss IBD Cohort Investigators, Wiest R, Stelling J, Macpherson AJ.

Nat Med. 2019 Feb;25(2):323-336. doi: 10.1038/s41591-018-0308-z. Epub 2019 Jan 21. Erratum in: Nat Med. 2019 Apr;25(4):701.

PMID:
30664783
7.

The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation.

Tcymbarevich IV, Eloranta JJ, Rossel JB, Obialo N, Spalinger M, Cosin-Roger J, Lang S, Kullak-Ublick GA, Wagner CA, Scharl M, Seuwen K, Ruiz PA, Rogler G, de Vallière C, Misselwitz B; Swiss IBD Cohort Study Group.

BMC Gastroenterol. 2019 Jan 7;19(1):2. doi: 10.1186/s12876-018-0922-8.

8.

Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.

Pittet VEH, Maillard MH, Simonson T, Fournier N, Rogler G, Michetti P; Swiss IBD Cohort Study Group(∗).

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2050-2059.e1. doi: 10.1016/j.cgh.2018.11.029. Epub 2018 Nov 22.

PMID:
30471455
9.

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course.

Greuter T, Piller A, Fournier N, Safroneeva E, Straumann A, Biedermann L, Godat S, Nydegger A, Scharl M, Rogler G, Vavricka SR, Schoepfer AM; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2018 Nov 28;12(12):1399-1409. doi: 10.1093/ecco-jcc/jjy121.

PMID:
30165603
10.

Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland.

Guilcher K, Fournier N, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1159-1167. doi: 10.1097/MEG.0000000000001197.

PMID:
29985208
11.

Autoimmune Gastritis in the Pediatric Age: An Underestimated Condition Report of Two Cases and Review.

Saglietti C, Sciarra A, Abdelrahman K, Schneider V, Karpate A, Nydegger A, Sempoux C.

Front Pediatr. 2018 May 1;6:123. doi: 10.3389/fped.2018.00123. eCollection 2018.

12.

The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort.

Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M; Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1768-1779. doi: 10.1093/ibd/izy054.

13.

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.

Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group .

J Crohns Colitis. 2018 Jun 28;12(7):811-818. doi: 10.1093/ecco-jcc/jjy040.

PMID:
29617750
14.

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.

Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):612-620. doi: 10.1097/MEG.0000000000001078.

15.

Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.

Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Spalinger J, Schibli S, Petit LM, Braegger CP; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):598-607. doi: 10.1097/MEG.0000000000001072.

PMID:
29360691
16.

Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease.

Lang BM, Biedermann L, van Haaften WT, de Vallière C, Schuurmans M, Begré S, Zeitz J, Scharl M, Turina M, Greuter T, Schreiner P, Heinrich H, Kuntzen T, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group.

Aliment Pharmacol Ther. 2018 Jan;47(1):55-66. doi: 10.1111/apt.14378. Epub 2017 Oct 20.

17.

Nutrient intake of Swiss toddlers.

Brunner TA, Casetti L, Haueter P, Müller P, Nydegger A, Spalinger J.

Eur J Nutr. 2018 Oct;57(7):2489-2499. doi: 10.1007/s00394-017-1521-0. Epub 2017 Aug 10.

PMID:
28812189
18.

The Use of 5-Aminosalicylic Acid in Children and Adolescents With Inflammatory Bowel Disease.

Sokollik C, Fournier N, Rizzuti D, Braegger CP, Nydegger A, Schibli S, Spalinger J; Swiss IBD Cohort Study Group.

J Clin Gastroenterol. 2018 Nov/Dec;52(10):e87-e91. doi: 10.1097/MCG.0000000000000864.

19.

Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.

Martin FP, Su MM, Xie GX, Guiraud SP, Kussmann M, Godin JP, Jia W, Nydegger A.

World J Gastroenterol. 2017 May 28;23(20):3643-3654. doi: 10.3748/wjg.v23.i20.3643.

20.

Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients.

Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Braegger CP; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2017 Aug;29(8):926-931. doi: 10.1097/MEG.0000000000000896.

Supplemental Content

Loading ...
Support Center